Cure My Disease
Don't miss your cure!
Clinical trials sponsored by L & L Bio Co., Ltd., Ningbo, China, explained in plain language.
This clinical trial is testing whether a combination of two immunotherapy drugs (LB1410 and LB4330) plus a targeted therapy (lenvatinib) can shrink tumors or slow disease progression in people with advanced cervical cancer that has returned or spread. The study will compare this …
Phase: PHASE2, PHASE3 • Sponsor: L & L Bio Co., Ltd., Ningbo, China • Aim: Disease control
Last updated Jun 26, 2026 17:31 UTC